Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Chest MedicineReference
Affairs DOEAS, Population. United Nations, Department of Economic and Social Affairs, Population Division (2013). World Population Prospects: the 2012 Revision, Highlights and Advance Tables. Working Paper No. ESA/P/WP.228.; 2013.
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.Lancet. 2012; 380: 37-43
- Early-life origins of chronic obstructive pulmonary disease.N Engl J Med. 2016; 375: 871-878
- COPD: time to improve its taxonomy?.ERJ Open Res. 2018; 4: 1-8
- Characterisation of COPD heterogeneity in the ECLIPSE cohort.Respir Res. 2010; 11: 122
- The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med. 2004; 350: 1005-1012
- Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: evidence from the epichron cohort.PLoS One. 2018; 13: e0193143
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet. 2017; 390: 1151-1210
- Ascertainment of cause-specific mortality in COPD: operations of the TORCH clinical Endpoint Committee.Thorax. 2007; 62: 411-415
- Mortality in COPD: role of comorbidities.Eur Respir J. 2006; 28: 1245-1257
- Lung function in early adulthood and health in later life: a transgenerational cohort analysis.Lancet Respir Med. 2017; 5: 935-945
- Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2012; 186: 155-161
- Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2013; 187: 728-735
- Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization.Arch Intern Med. 2000; 160: 2653-2658
- Prevalence of comorbidities in patients with chronic obstructive pulmonary disease.Respiration. 2010; 80: 112-119
- Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40.J Clin Epidemiol. 2001; 54: 287-293
- The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.BMC Pulm Med. 2012; 12: 26
- Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.Chronic Obstr Pulm Dis. 2014; 1: 105-114
- Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation.Thorax. 2008; 63: 487-492
- Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study.Lung. 2010; 188: 321-329
- Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study.Chest. 2012; 142: 1126-1133
- Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease.Eur Respir J. 1997; 10: 2794-2800
- Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD.Am J Phys Med Rehabil. 2007; 86: 30-36
- Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.Eur Respir J. 2016; 47: 429-460
- The 6-minute-walk distance test as a chronic obstructive pulmonary disease stratification tool. Insights from the COPD biomarker qualification Consortium.Am J Respir Crit Care Med. 2016; 194: 1483-1493
- Use of pedometers as a tool to promote daily physical activity levels in patients with COPD: a systematic review and meta-analysis.Eur Respir Rev. 2019; 28: 190039
- Peripheral muscle composition and health status in patients with COPD.Respir Med. 2006; 100: 1800-1806
- Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease.Thorax. 2007; 62: 115-120
- Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease.Eur Respir J. 2001; 17: 939-945
- Impact of COPD exacerbations on patient-centered outcomes.Chest. 2015; 131: 696-704
- The relevance of limb muscle dysfunction in chronic obstructive pulmonary disease: a review for clinicians.Clin Chest Med. 2019; 40: 367-383
- Deterioration of limb muscle function during acute exacerbation of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2018; 197: 433-449
- The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature.Chest. 2005; 127: 1952-1959
- Coexistent chronic obstructive pulmonary disease and heart failure in the elderly.Int J Cardiol. 2008; 125: 209-215
- Percent emphysema, airflow obstruction, and impaired left ventricular filling.N Engl J Med. 2010; 362: 217-227
- Pulmonary arterial enlargement and acute exacerbations of COPD.N Engl J Med. 2012; 367: 913-921
- Pulmonary arterial enlargement predicts long-term survival in COPD patients.PLoS One. 2018; 13 (e0195640–13)
- The link between reduced inspiratory capacity and exercise intolerance in chronic obstructive pulmonary disease.Ann Am Thorac Soc. 2017; 14: S30-S39
- Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease.Am Rev Respir Dis. 1988; 138: 350-354
- Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers.Am J Respir Crit Care Med. 2007; 176: 285-290
- Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.Chest. 2007; 132: 1932-1938
- Reduced lung-cancer mortality with volume CT screening in a randomized trial.N Engl J Med. 2020; 382: 503-513
- Anxiety and depression in chronic obstructive pulmonary disease: recognition and management.Cleve Clin J Med. 2018; 85: S11-S18
- Anxiety and depression in end-stage COPD.Eur Respir J. 2008; 31: 667-677
- Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression.Psychosomatics. 2006; 47: 312-319
- Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life.Arch Intern Med. 2006; 167: 60-67
- Osteoporosis in chronic obstructive pulmonary disease patients.Curr Opin Pulm Med. 2008; 14: 122-127
- Clinical practice. Osteoporosis in men.N Engl J Med. 2008; 358: 1474-1482
- Complex chronic comorbidities of COPD.Eur Respir J. 2008; 31: 204-212
- Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome.Am J Respir Crit Care Med. 2010; 182: 325-331
- Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases.Int J Cardiol. 2006; 111: 365-370
- Haemoglobin level and its clinical impact in a cohort of patients with COPD.Eur Respir J. 2007; 29: 923-929
- Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.JAMA. 2005; 294: 716-724
- Management of chronic obstructive pulmonary disease beyond the lungs.Lancet Respir Med. 2016; 4: 911-924
- Tailoring the approach to multimorbidity in adults with respiratory disease: the NICE guideline.Eur Respir J. 2017; 49: 1601696
- How to integrate multiple comorbidities in guideline development: article 10 in integrating and coordinating efforts in COPD guideline development. an official ATS/ERS Workshop Report.Proc Am Thorac Soc. 2012; 9: 274-281
- Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.N Engl J Med. 2007; 356: 775-789
- Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomized controlled trial.Lancet. 2016; 387: 1817-1826
Mignot J. Strategic behavior in road cycling competitions. The Economics of Professional Road Cycling https://doi.org/10.1007/978-3-319-22312-4.
- A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives.Int J Epidemiol. 2002; 31: 285-293
- Lung-function trajectories leading to chronic obstructive pulmonary disease.N Engl J Med. 2015; 373: 111-122
- Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients.Nat Commun. 2014; 5: 1769
- Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis.Thorax. 2005; 60: 570-575
- Identification of COPD patients at high risk for lung cancer mortality using the COPD-LUCSS-DLCO.Chest. 2016; 149: 936-942
- COPD comorbidities network.Eur Respir J. 2015; 46: 640-650
- Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis.Ann Am Thorac Soc. 2015; 12: 303-312
- Clinical COPD phenotypes: a novel approach using principal component and cluster analyses.Eur Respir J. 2010; 36: 531-539
- A simple algorithm for the identification of clinical COPD phenotypes.Eur Respir J. 2017; 50: 1701034
- Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.Thorax. 2011; 66: 430-437
- Human disease classification in the postgenomic era: a complex systems approach to human pathobiology.Mol Syst Biol. 2007; 3: 124
- Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype.Eur Respir J. 2018; 51: 1702146
- Respiratory insufficiency.Lancet. 1955; 268: 1185-1187